CACNG8

CACNG8 encodes TARP γ-8, an auxiliary AMPA receptor regulatory protein that physically associates with the pore-forming AMPAR subunit to govern synaptic glutamatergic signaling (PMID:26989142). Novel AMPAR modulators act through TARP γ-8 by partially disrupting its interaction with the channel pore subunit, an effect dependent on intact TARP γ-8 and mapped using mutant constructs in calcium flux, radioligand binding, and electrophysiological assays (PMID:26989142). In vivo, loss of TARP γ-8 disrupts the synaptic AMPAR complex in hippocampal synaptosomes and dysregulates dopaminergic and glutamatergic transmission in the prefrontal cortex, producing behavioral deficits rescuable by methylphenidate (PMID:36031768). Its expression is sensitive to a transcription-suppressing SNP (rs10420324G) acting through a local G-quadruplex structure, and reduced gene dosage in heterozygous mice impairs synaptic AMPAR function in layer 2–3 prefrontal pyramidal neurons (PMID:34099816).

1. 2016 High

   Established that TARP γ-8 physically engages the AMPAR pore-forming subunit and that this interface is pharmacologically targetable, defining the molecular basis for its modulatory role.

   Evidence Calcium flux, radioligand binding, and electrophysiology with wild-type and mutant TARP γ-8 constructs plus in vivo occupancy

   PMID:26989142

   Open questions at the time

   • No structural model of the TARP γ-8–pore subunit interface resolved here
   • Endogenous physiological consequence of disrupting the interaction not assessed in vivo
   • Specific residues mediating the interaction not fully mapped
2. 2021 Medium

   Linked CACNG8 gene dosage and a transcription-regulatory SNP to AMPAR function in defined cortical neurons, connecting expression control to synaptic physiology.

   Evidence Reporter gene assay for transcriptional effect plus electrophysiology in knockout and heterozygous mice

   PMID:34099816

   Open questions at the time

   • G-quadruplex mechanism inferred, not directly demonstrated at the endogenous locus
   • Single lab, two methods
   • Behavioral relevance of the SNP in humans not established
3. 2022 Medium

   Demonstrated that whole-animal loss of TARP γ-8 disrupts the synaptic AMPAR complex and broader neurotransmission, with a pharmacological rescue defining a tractable circuit-level deficit.

   Evidence Knockout mice with synaptosomal proteomics, behavioral phenotyping, and methylphenidate rescue

   PMID:36031768

   Open questions at the time

   • Mechanism connecting AMPAR complex loss to dopaminergic dysregulation unresolved
   • Single lab
   • Cell-type specificity of the proteomic changes not dissected
4. 2025 Low

   Proposed that rare human CACNG8 variants destabilize the postsynaptic AMPAR-associated complex, extending the gene's role to potential human disease.

   Evidence Whole exome sequencing with molecular docking, free-energy calculations, and molecular dynamics simulations

   PMID:41127817

   Open questions at the time

   • Computational modeling only, no in vitro or in vivo functional validation of variants
   • Stability predictions not confirmed by biochemical measurement
   • Causal genotype-phenotype link in patients not established

• How TARP γ-8 dosage and complex integrity mechanistically couple to prefrontal dopaminergic regulation and human neuropsychiatric phenotypes remains unresolved.
• No experimental validation of disease-associated variants
• Structural mechanism of complex stabilization uncharacterized in the corpus
• Direct partners beyond the AMPAR pore subunit not biochemically mapped